142 related articles for article (PubMed ID: 21371556)
1. Experimental design for optimizing drug release from silicone elastomer matrix and investigation of transdermal drug delivery.
Snorradóttir BS; Gudnason PI; Thorsteinsson F; Másson M
Eur J Pharm Sci; 2011 Apr; 42(5):559-67. PubMed ID: 21371556
[TBL] [Abstract][Full Text] [Related]
2. Release of anti-inflammatory drugs from a silicone elastomer matrix system.
Snorradóttir BS; Gudnason PI; Scheving R; Thorsteinsson F; Másson M
Pharmazie; 2009 Jan; 64(1):19-25. PubMed ID: 19216226
[TBL] [Abstract][Full Text] [Related]
3. Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial.
Malcolm RK; McCullagh SD; Woolfson AD; Gorman SP; Jones DS; Cuddy J
J Control Release; 2004 Jun; 97(2):313-20. PubMed ID: 15196758
[TBL] [Abstract][Full Text] [Related]
4. Transdermal delivery of diclofenac sodium through rat skin from various formulations.
Sarigüllü Ozgüney I; Yeşim Karasulu H; Kantarci G; Sözer S; Güneri T; Ertan G
AAPS PharmSciTech; 2006 Oct; 7(4):88. PubMed ID: 17233540
[TBL] [Abstract][Full Text] [Related]
5. Numerical modelling of transdermal delivery from matrix systems: parametric study and experimental validation with silicone matrices.
Snorradóttir BS; Jónsdóttir F; Sigurdsson ST; Másson M
J Pharm Sci; 2014 Aug; 103(8):2366-75. PubMed ID: 24984880
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies.
Liu D; Ge Y; Tang Y; Yuan Y; Zhang Q; Li R; Xu Q
J Microencapsul; 2010; 27(8):726-34. PubMed ID: 21034365
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proxyphylline's release from silicone rubber matrices by the use of osmotically active excipients and a multi-layer system.
Soulas DN; Papadokostaki KG
Int J Pharm; 2011 Apr; 408(1-2):120-9. PubMed ID: 21335074
[TBL] [Abstract][Full Text] [Related]
9. Effect of nano-oxide concentration on the mechanical properties of a maxillofacial silicone elastomer.
Han Y; Kiat-amnuay S; Powers JM; Zhao Y
J Prosthet Dent; 2008 Dec; 100(6):465-73. PubMed ID: 19033031
[TBL] [Abstract][Full Text] [Related]
10. Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(6):28-33. PubMed ID: 10171149
[TBL] [Abstract][Full Text] [Related]
11. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
Efentakis M; Naseef H; Vlachou M
Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
[TBL] [Abstract][Full Text] [Related]
12. Damar Batu as a novel matrix former for the transdermal drug delivery: in vitro evaluation.
Mundada AS; Avari JG
Drug Dev Ind Pharm; 2009 Sep; 35(9):1147-54. PubMed ID: 19555240
[TBL] [Abstract][Full Text] [Related]
13. The effects of primers and surface bonding characteristics on the adhesion of polyurethane to two commonly used silicone elastomers.
Chang PP; Hansen NA; Phoenix RD; Schneid TR
J Prosthodont; 2009 Jan; 18(1):23-31. PubMed ID: 19166545
[TBL] [Abstract][Full Text] [Related]
14. Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.
Pfister WR; Hsieh DS
Med Device Technol; 1990; 1(5):48-55. PubMed ID: 10171148
[TBL] [Abstract][Full Text] [Related]
15. Effect of different penetration enhancers on diclofenac permeation across horse skin.
Ferrante M; Andreeta A; Landoni MF
Vet J; 2010 Dec; 186(3):312-5. PubMed ID: 19815433
[TBL] [Abstract][Full Text] [Related]
16. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable derivatives of tranexamic acid as transdermal permeation enhancers.
Vávrová K; Hrabálek A; Dolezal P; Holas T; Klimentová J
J Control Release; 2005 May; 104(1):41-9. PubMed ID: 15866333
[TBL] [Abstract][Full Text] [Related]
18. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
19. Transdermal drug delivery systems: skin perturbation devices.
Brown MB; Traynor MJ; Martin GP; Akomeah FK
Methods Mol Biol; 2008; 437():119-39. PubMed ID: 18369965
[TBL] [Abstract][Full Text] [Related]
20. Design and in vivo evaluation of an indapamide transdermal patch.
Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
